Winston-Salem regenerative medicine community launches clinical trials program
Winston-Salem is adding three healthcare diagnostics companies and a new clinical trials program to its growing regenerative medicine community.
Read More
regenerative medicine
Winston-Salem’s RegenMed Hub welcomes Immunaeon amidst expansion
The New York-based Immunaeon will join the RegeneratOR Innovation AcceleratOR, which is located in the Regenerative Medicine Hub in Winston-Salem.
Read More
Former FDA official joins Winston-Salem-based RegenMed Hub
In what one executive called a ‘coup,’ the Winston-Salem organization RegenMed Hub will bring in a former FDA official to help its startups accelerate growth.
Read More
Regenerative medicine advanced manufacturing is new target for SAS’ data analytics
The nonprofit Regenerative Medicine Development Organization (ReMDO) in Winston-Salem and Cary-based analytics company SAS are joining forces to improve advanced manufacturing for regenerative medicine applications.
Read More
Regenerative Medicine Hub at W-S Innovation Quarter keeps growing with new addition
A Georgia company that specializes in placental biologics is the latest company to establish a presence in Winston-Salem’s Regenerative Medicine Hub, a growing ecosystem for regenerative medicine research, development and manufacturing. Check out our latest Innovation Thursday feature, this week coming from the N.C. Biotech Center.
Read More
Axiom Space partnership will target regenerative medicine manufacturing in space
Axiom Space will lease a facility in Winston-Salem to lay groundwork for research on regenerative medicine as it prepares to launch its space station.
Read More
Space station builder to lease space in Winston-Salem regenerative medicine accelerator
A commercial space company that is building a space station and launched its first mission earlier this month will lease space in Winston-Salem.
Read MoreHumacyte advances bioengineered blood vessel tech in vascular trauma clinical trial
Humacyte, a Durham-based regenerative medicine company, has begun another clinical trial of Humacyl, its bioengineered blood vessel, this time in patients with vascular trauma.
Read More
